odo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine), as referred to in Council Implementing Decision (EU) 2015/1875 [8].
ada-2,5-dé-mheatocsa-N-(2-meatocsaibeinsil)feineitiolaimín (25I-NBOMe), 3,4-déchlóra-N-[[1- (démheitiolaimín)cioglaiheicsil]meitil]beansaimíd (AH-7921), 3,4-meitiléindé-ocsaipireavaléarón (MDPV) agus 2-(3-meatocsaifeinil)-2-(eitilaimíni)cioglaiheacsanón (meatocsataimín), dá dtagraítear i gCinneadh Cur Chun Feidhme (AE) 2015/1875 ón gComhairle [8].